Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 395 results found. Search for [ SARS CoV-2 ]

Results 1 to 21 of 395
PTI
June 12, 2021
Prior infections, high seropositivity and partial vaccination are \"insufficient impediments\" to the spread of the Delta variant, found the scientists


BusinessToday.In
June 11, 2021
Through its virtual reality (VR) app, US-based startup Nanome licenses its technology to scientists in their research of diseases as well as pharma companies aiming to design new drugs


PTI
June 11, 2021
In their latest report, medical experts from IPHA, IAPSM, and IAE said vaccinating the vulnerable and those at risk should be the aim at present


PTI
June 11, 2021
The Hyderabad-based firm said it has developed the product which is backward integrated with its in-house API (Active Pharmaceutical Ingredient)


BusinessToday.In
June 10, 2021
Both patients were given REGCov2, which has been developed to produce resistance against SARS-CoV-2. Both COVID-19 patients managed to recover from their ailments and were discharged within 12 hours


BusinessToday.In
June 9, 2021
It is very hard to conclusively state whether this virus is of natural or lab origin, unlike the publications which state that it cannot be of lab origin, said the researchers, led by Prof Biswajit Kundu, in a statement


BusinessToday.In
June 9, 2021
The AIIMS chief added that 60-70 per cent of children who were admitted to hospitals due to COVID-19 second wave either had comorbidities or low immunity


BusinessToday.In
New Delhi, June 8, 2021
The origin of COVID-19 is mysterious darkness. Scientists are unaware of where the coronavirus identified as SARS-CoV-2 came from. The current debate is focused on whether SARS-CoV-2 emerged from China's Wuhan Institute of Virology (WIV) or a natural source. A Wall Street Journal 2021 report claimed that the novel coronavirus was leaked from a Wuhan-based lab in China. In response, the Chinese government accused the US of 'spreading conspiracy theories' with US President Joe Biden asking officials to 'redouble' their efforts to probe the origin of the COVID-19 pandemic. The former also urged the US government to open its virology facilities for scrutiny. This came amid growing calls for a full-scale probe of whether the coronavirus escaped from China's bio lab. Watch the video for more.Also Read: 'China has not eradicated poverty': Xi Jinping govt's claims challenged


BusinessToday.In
June 7, 2021
The study has noted that both Covishield and Covaxin produce a good response after the two doses have been administered. However, seropositivity rate and median anti-spike antibody were significantly higher in Covishield recipients


Vivek Dubey
June 4, 2021
The pride were immediately attended to by the veterinary team in the zoo. In addition to this, a team of experts was also deputed by Tamil Nadu Veterinary and Animal Sciences University (TANUVAS) to help the veterinarians in the zoo to investigate the condition of the lions


PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.


PTI
June 1, 2021
Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules


PTI
June 1, 2021
The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an \"Indian Variant\" in media reports


PTI
May 31, 2021
The origins of the COVID-19 remain a widely debated topic, with some scientists and politicians maintaining that the possibility of a lab leak of the deadly virus exists


BusinessToday.In
May 31, 2021
Not having complete know-how about the origins of the pandemic puts the world at risk of future pandemics, according to the co-director of the Texas Children's Hospital Center for Vaccine Development Peter Hotez


Reuters
May 28, 2021
The Chinese embassy in Washington said in a statement on its website that \"some political forces have been fixated on political manipulation and (the) blame game\"


PB Jayakumar
May 27, 2021
Zydus is the only Indian company which claims to have developed a neutralising monoclonal antibodies (mAbs) based cocktail for the treatment of COVID 19


BusinessToday.In
May 27, 2021
Two vaccines developed by China National Biotech Group Co, which is a unit of Sinopharm, showed the efficacy of 72.8 per cent and 78.1 per cent, respectively. The current efficacy rate largely falls in line with Sinopharm's previous claims


BusinessToday.In
May 27, 2021
Pfizer told Indian authorities that its vaccine has demonstrated \"high effectiveness\" against the COVID-19 variant prevalent in India and on people of Indian ethnicity or nationality


BusinessToday.In
May 25, 2021
WHO's EUL authorisation is a pre-requisite for COVAX facility, which is meant to ensure COVID-19 vaccine supply to poorer nations. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines


PAGES 1 OF 20  12345